Targeted Medicines for Melanoma Are Effective in Targeting a Specific Mutation

Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated March 3rd, 2022

Targeted Medicines for Melanoma Are Effective in Targeting a Specific Mutation

NOW
PLAYING
ESPN Sports Commentator Holly Rowe, 58, Insists 'No Tan Is Worth What I've Been Through' After Aggressive Skin Cancer Battle
NOW
PLAYING
Why Model Elle Macpherson's Breast Cancer Treatment Decision Is Not Necessarily So Controversial; The Serious Study of Overtreatment
NOW
PLAYING
Dancing With The Stars Alum Samantha Harris, 50, Announces Second Breast Cancer Diagnosis- Her Treatment Options
NOW
PLAYING
Exciting Progress for Difficult-to-Treat Advanced Melanoma — What to Know About Biologic Drug Brenetafusp
NOW
PLAYING
A Powerful Tool: Integrating Venetoclax into CLL Management Improves Survival
NOW
PLAYING
Physicians Advised to Consider Rybrevant for EGFR Mutation-Positive NSCLC, Following FDA Approval

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... melanoma trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider